Researchers in Detroit say they have identified a naturally occurring genetic variant that appears to lower the risk of ...

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University and institutions across the U.S.

A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...

A newly identified loss of cellular identity may enable colorectal cancer cells to enter a highly flexible state that ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

The development of cancer is not a process triggered immediately by the emergence of an oncogenic mutation. There is growing ...

At MSK, close to half of the surgeries just for colorectal cancer are done robotically, Dr. Garcia-Aguilar says. A leader in ...

Colorectal cancer (CRC) arises through a combination of inherited and acquired genetic alterations that disrupt key pathways of DNA repair, cell growth and immune surveillance. Germline variants in ...

An international, interdisciplinary research team led by Prof. Jakob N. Kather from the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology analyzed seven ...

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...